Frontiers in Genetics (Nov 2022)
Multifactor dimensionality reduction reveals the effect of interaction between ERAP1 and IFIH1 polymorphisms in psoriasis susceptibility genes
- Chang Zhang,
- Chang Zhang,
- Chang Zhang,
- Chang Zhang,
- Chang Zhang,
- Qin Qin,
- Qin Qin,
- Qin Qin,
- Qin Qin,
- Qin Qin,
- Yuanyuan Li,
- Yuanyuan Li,
- Yuanyuan Li,
- Yuanyuan Li,
- Yuanyuan Li,
- Xiaodong Zheng,
- Xiaodong Zheng,
- Xiaodong Zheng,
- Xiaodong Zheng,
- Xiaodong Zheng,
- Weiwei Chen,
- Weiwei Chen,
- Weiwei Chen,
- Weiwei Chen,
- Weiwei Chen,
- Qi Zhen,
- Qi Zhen,
- Qi Zhen,
- Qi Zhen,
- Qi Zhen,
- Bao Li,
- Bao Li,
- Bao Li,
- Bao Li,
- Bao Li,
- Wenjun Wang,
- Wenjun Wang,
- Wenjun Wang,
- Wenjun Wang,
- Wenjun Wang,
- Liangdan Sun,
- Liangdan Sun,
- Liangdan Sun,
- Liangdan Sun,
- Liangdan Sun
Affiliations
- Chang Zhang
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China
- Chang Zhang
- Institute of Dermatology, Anhui Medical University, Hefei, China
- Chang Zhang
- Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China
- Chang Zhang
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China
- Chang Zhang
- Anhui Provincial Institute of Translational Medicine, Hefei, China
- Qin Qin
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China
- Qin Qin
- Institute of Dermatology, Anhui Medical University, Hefei, China
- Qin Qin
- Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China
- Qin Qin
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China
- Qin Qin
- Anhui Provincial Institute of Translational Medicine, Hefei, China
- Yuanyuan Li
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China
- Yuanyuan Li
- Institute of Dermatology, Anhui Medical University, Hefei, China
- Yuanyuan Li
- Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China
- Yuanyuan Li
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China
- Yuanyuan Li
- Anhui Provincial Institute of Translational Medicine, Hefei, China
- Xiaodong Zheng
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China
- Xiaodong Zheng
- Institute of Dermatology, Anhui Medical University, Hefei, China
- Xiaodong Zheng
- Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China
- Xiaodong Zheng
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China
- Xiaodong Zheng
- Anhui Provincial Institute of Translational Medicine, Hefei, China
- Weiwei Chen
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China
- Weiwei Chen
- Institute of Dermatology, Anhui Medical University, Hefei, China
- Weiwei Chen
- Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China
- Weiwei Chen
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China
- Weiwei Chen
- Anhui Provincial Institute of Translational Medicine, Hefei, China
- Qi Zhen
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China
- Qi Zhen
- Institute of Dermatology, Anhui Medical University, Hefei, China
- Qi Zhen
- Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China
- Qi Zhen
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China
- Qi Zhen
- Anhui Provincial Institute of Translational Medicine, Hefei, China
- Bao Li
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China
- Bao Li
- Institute of Dermatology, Anhui Medical University, Hefei, China
- Bao Li
- Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China
- Bao Li
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China
- Bao Li
- Anhui Provincial Institute of Translational Medicine, Hefei, China
- Wenjun Wang
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China
- Wenjun Wang
- Institute of Dermatology, Anhui Medical University, Hefei, China
- Wenjun Wang
- Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China
- Wenjun Wang
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China
- Wenjun Wang
- Anhui Provincial Institute of Translational Medicine, Hefei, China
- Liangdan Sun
- Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, China
- Liangdan Sun
- Institute of Dermatology, Anhui Medical University, Hefei, China
- Liangdan Sun
- Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China
- Liangdan Sun
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, China
- Liangdan Sun
- Anhui Provincial Institute of Translational Medicine, Hefei, China
- DOI
- https://doi.org/10.3389/fgene.2022.1009589
- Journal volume & issue
-
Vol. 13
Abstract
Background: Psoriasis is a common immune-mediated hyperproliferative skin dysfunction with known genetic predisposition. Gene–gene interaction (e.g., between HLA-C and ERAP1) in the psoriasis context has been reported in various populations. As ERAP1 has been recognized as a psoriasis susceptibility gene and plays a critical role in antigen presentation, we performed this study to identify interactions between ERAP1 and other psoriasis susceptibility gene variants.Methods: We validated psoriasis susceptibility gene variants in an independent cohort of 5,414 patients with psoriasis and 5,556 controls. Multifactor dimensionality reduction (MDR) analysis was performed to identify the interaction between variants significantly associated with psoriasis in the validation cohort and ERAP1 variants. We then conducted a meta-analysis of those variants with datasets from exome sequencing, target sequencing, and validation analyses and used MDR to identify the best gene–gene interaction model, including variants that were significant in the meta-analysis and ERAP1 variants.Results: We found that 19 of the replicated variants were identified with p < 0.05 and detected six single-nucleotide polymorphisms of psoriasis susceptibility genes in the meta-analysis. MDR analysis revealed that the best predictive model was that between the rs27044 polymorphism of ERAP1 and the rs7590692 polymorphism of IFIH1 (cross-validation consistency = 9/10, test accuracy = 0.53, odds ratio = 1.32 (95% CI, 1.09–1.59), p < 0.01).Conclusion: Our findings suggest that the interaction between ERAP1 and IFIH1 affects the development of psoriasis. This hypothesis needs to be tested in basic biological studies.
Keywords
- psoriasis
- gene–gene interaction
- multifactor dimensionality reduction
- genome-wide association studies
- IFIH1
- ERAP1